Industry Research Reports

Home > Reports > Chemical & Material > Global Cefoperazone Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Cefoperazone Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-21

Pages: 95 Pages

Report ld: 4162303

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Cefoperazone Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.

The North America Cefoperazone Sodium market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Cefoperazone Sodium include ACS Dobfar, Sterile India, Nectar Lifesciences, Orchid Pharma, Qilu Pharmaceutial, Sinopharm Weiqida Pharmaceutical, United Laboratories International Holdings, Dawnrays, Hebei Hejia Pharmaceutical, Luoxin Pharmaceutical, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Cefoperazone Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cefoperazone Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

ACS Dobfar
Sterile India
Nectar Lifesciences
Orchid Pharma
Qilu Pharmaceutial
Sinopharm Weiqida Pharmaceutical
United Laboratories International Holdings
Dawnrays
Hebei Hejia Pharmaceutical
Luoxin Pharmaceutical
Youcare Pharmaceutical Group
Rajasthan Antibiotics
Shanghai Xinya Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity≥98%
Purity<98%

Segment by Application

Cefoperazone Sodium Injection
Other

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Cefoperazone Sodium Product Scope

1.2 Cefoperazone Sodium by Type

1.2.1 Global Cefoperazone Sodium Sales by Type (2020 & 2024 & 2031)

1.2.2 Purity≥98%

1.2.3 Purity

TABLE OF FIGURES

List of Tables

Table 1. Global Cefoperazone Sodium Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Cefoperazone Sodium Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Cefoperazone Sodium Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Cefoperazone Sodium Sales (MT) by Region (2020-2025)

Table 5. Global Cefoperazone Sodium Sales Market Share by Region (2020-2025)

Table 6. Global Cefoperazone Sodium Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Cefoperazone Sodium Revenue Share by Region (2020-2025)

Table 8. Global Cefoperazone Sodium Sales (MT) Forecast by Region (2026-2031)

Table 9. Global Cefoperazone Sodium Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Cefoperazone Sodium Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Cefoperazone Sodium Revenue Share Forecast by Region (2026-2031)

Table 12. Global Cefoperazone Sodium Sales by Type (MT) & (2020-2025)

Table 13. Global Cefoperazone Sodium Sales Share by Type (2020-2025)

Table 14. Global Cefoperazone Sodium Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Cefoperazone Sodium Price by Type (USD/Kg) & (2020-2025)

Table 16. Global Cefoperazone Sodium Sales by Type (MT) & (2026-2031)

Table 17. Global Cefoperazone Sodium Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Cefoperazone Sodium Price by Type (USD/Kg) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Cefoperazone Sodium Sales by Application (MT) & (2020-2025)

Table 21. Global Cefoperazone Sodium Sales Share by Application (2020-2025)

Table 22. Global Cefoperazone Sodium Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Cefoperazone Sodium Price by Application (USD/Kg) & (2020-2025)

Table 24. Global Cefoperazone Sodium Sales by Application (MT) & (2026-2031)

Table 25. Global Cefoperazone Sodium Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Cefoperazone Sodium Price by Application (USD/Kg) & (2026-2031)

Table 27. New Sources of Growth in Cefoperazone Sodium Application

Table 28. Global Cefoperazone Sodium Sales by Company (MT) & (2020-2025)

Table 29. Global Cefoperazone Sodium Sales Share by Company (2020-2025)

Table 30. Global Cefoperazone Sodium Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Cefoperazone Sodium Revenue Share by Company (2020-2025)

Table 32. Global Cefoperazone Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefoperazone Sodium as of 2024)

Table 33. Global Market Cefoperazone Sodium Average Price by Company (USD/Kg) & (2020-2025)

Table 34. Global Key Manufacturers of Cefoperazone Sodium, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Cefoperazone Sodium, Product Type & Application

Table 36. Global Key Manufacturers of Cefoperazone Sodium, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Cefoperazone Sodium Sales by Company (2020-2025) & (MT)

Table 39. North America Cefoperazone Sodium Sales Market Share by Company (2020-2025)

Table 40. North America Cefoperazone Sodium Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Cefoperazone Sodium Revenue Market Share by Company (2020-2025)

Table 42. North America Cefoperazone Sodium Sales by Type (2020-2025) & (MT)

Table 43. North America Cefoperazone Sodium Sales Market Share by Type (2020-2025)

Table 44. North America Cefoperazone Sodium Sales by Application (2020-2025) & (MT)

Table 45. North America Cefoperazone Sodium Sales Market Share by Application (2020-2025)

Table 46. Europe Cefoperazone Sodium Sales by Company (2020-2025) & (MT)

Table 47. Europe Cefoperazone Sodium Sales Market Share by Company (2020-2025)

Table 48. Europe Cefoperazone Sodium Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Cefoperazone Sodium Revenue Market Share by Company (2020-2025)

Table 50. Europe Cefoperazone Sodium Sales by Type (2020-2025) & (MT)

Table 51. Europe Cefoperazone Sodium Sales Market Share by Type (2020-2025)

Table 52. Europe Cefoperazone Sodium Sales by Application (2020-2025) & (MT)

Table 53. Europe Cefoperazone Sodium Sales Market Share by Application (2020-2025)

Table 54. China Cefoperazone Sodium Sales by Company (2020-2025) & (MT)

Table 55. China Cefoperazone Sodium Sales Market Share by Company (2020-2025)

Table 56. China Cefoperazone Sodium Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Cefoperazone Sodium Revenue Market Share by Company (2020-2025)

Table 58. China Cefoperazone Sodium Sales by Type (2020-2025) & (MT)

Table 59. China Cefoperazone Sodium Sales Market Share by Type (2020-2025)

Table 60. China Cefoperazone Sodium Sales by Application (2020-2025) & (MT)

Table 61. China Cefoperazone Sodium Sales Market Share by Application (2020-2025)

Table 62. Japan Cefoperazone Sodium Sales by Company (2020-2025) & (MT)

Table 63. Japan Cefoperazone Sodium Sales Market Share by Company (2020-2025)

Table 64. Japan Cefoperazone Sodium Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Cefoperazone Sodium Revenue Market Share by Company (2020-2025)

Table 66. Japan Cefoperazone Sodium Sales by Type (2020-2025) & (MT)

Table 67. Japan Cefoperazone Sodium Sales Market Share by Type (2020-2025)

Table 68. Japan Cefoperazone Sodium Sales by Application (2020-2025) & (MT)

Table 69. Japan Cefoperazone Sodium Sales Market Share by Application (2020-2025)

Table 70. ACS Dobfar Company Information

Table 71. ACS Dobfar Description and Business Overview

Table 72. ACS Dobfar Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. ACS Dobfar Cefoperazone Sodium Product

Table 74. ACS Dobfar Recent Development

Table 75. Sterile India Company Information

Table 76. Sterile India Description and Business Overview

Table 77. Sterile India Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Sterile India Cefoperazone Sodium Product

Table 79. Sterile India Recent Development

Table 80. Nectar Lifesciences Company Information

Table 81. Nectar Lifesciences Description and Business Overview

Table 82. Nectar Lifesciences Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. Nectar Lifesciences Cefoperazone Sodium Product

Table 84. Nectar Lifesciences Recent Development

Table 85. Orchid Pharma Company Information

Table 86. Orchid Pharma Description and Business Overview

Table 87. Orchid Pharma Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Orchid Pharma Cefoperazone Sodium Product

Table 89. Orchid Pharma Recent Development

Table 90. Qilu Pharmaceutial Company Information

Table 91. Qilu Pharmaceutial Description and Business Overview

Table 92. Qilu Pharmaceutial Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Qilu Pharmaceutial Cefoperazone Sodium Product

Table 94. Qilu Pharmaceutial Recent Development

Table 95. Sinopharm Weiqida Pharmaceutical Company Information

Table 96. Sinopharm Weiqida Pharmaceutical Description and Business Overview

Table 97. Sinopharm Weiqida Pharmaceutical Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Sinopharm Weiqida Pharmaceutical Cefoperazone Sodium Product

Table 99. Sinopharm Weiqida Pharmaceutical Recent Development

Table 100. United Laboratories International Holdings Company Information

Table 101. United Laboratories International Holdings Description and Business Overview

Table 102. United Laboratories International Holdings Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. United Laboratories International Holdings Cefoperazone Sodium Product

Table 104. United Laboratories International Holdings Recent Development

Table 105. Dawnrays Company Information

Table 106. Dawnrays Description and Business Overview

Table 107. Dawnrays Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. Dawnrays Cefoperazone Sodium Product

Table 109. Dawnrays Recent Development

Table 110. Hebei Hejia Pharmaceutical Company Information

Table 111. Hebei Hejia Pharmaceutical Description and Business Overview

Table 112. Hebei Hejia Pharmaceutical Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 113. Hebei Hejia Pharmaceutical Cefoperazone Sodium Product

Table 114. Hebei Hejia Pharmaceutical Recent Development

Table 115. Luoxin Pharmaceutical Company Information

Table 116. Luoxin Pharmaceutical Description and Business Overview

Table 117. Luoxin Pharmaceutical Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 118. Luoxin Pharmaceutical Cefoperazone Sodium Product

Table 119. Luoxin Pharmaceutical Recent Development

Table 120. Youcare Pharmaceutical Group Company Information

Table 121. Youcare Pharmaceutical Group Description and Business Overview

Table 122. Youcare Pharmaceutical Group Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 123. Youcare Pharmaceutical Group Cefoperazone Sodium Product

Table 124. Youcare Pharmaceutical Group Recent Development

Table 125. Rajasthan Antibiotics Company Information

Table 126. Rajasthan Antibiotics Description and Business Overview

Table 127. Rajasthan Antibiotics Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 128. Rajasthan Antibiotics Cefoperazone Sodium Product

Table 129. Rajasthan Antibiotics Recent Development

Table 130. Shanghai Xinya Pharma Company Information

Table 131. Shanghai Xinya Pharma Description and Business Overview

Table 132. Shanghai Xinya Pharma Cefoperazone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 133. Shanghai Xinya Pharma Cefoperazone Sodium Product

Table 134. Shanghai Xinya Pharma Recent Development

Table 135. Production Base and Market Concentration Rate of Raw Material

Table 136. Key Suppliers of Raw Materials

Table 137. Cefoperazone Sodium Distributors List

Table 138. Cefoperazone Sodium Customers List

Table 139. Cefoperazone Sodium Market Trends

Table 140. Cefoperazone Sodium Market Drivers

Table 141. Cefoperazone Sodium Market Challenges

Table 142. Cefoperazone Sodium Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Cefoperazone Sodium Product Picture

Figure 2. Global Cefoperazone Sodium Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Cefoperazone Sodium Sales Market Share by Type in 2024 & 2031

Figure 4. Purity≥98% Product Picture

Figure 5. Purity

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Cefoperazone Sodium market? zhanKai

The top companies in the global Cefoperazone Sodium market are ACS Dobfar、Sterile India、Nectar Lifesciences.

Related Reports

Cefoperazone Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cefoperazone Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 139
USD 3950.00
(Single User License)
Global Cefoperazone Sodium Market Research Report 2026
The global Cefoperazone Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 141
USD 2900.00
(Single User License)
Global Cefoperazone Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cefoperazone Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 158
USD 4900.00
(Single User License)
Global Cefoperazone Sodium Market Research Report 2025
The global market for Cefoperazone Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 104
USD 2900.00
(Single User License)
Cefoperazone Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cefoperazone Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 125
USD 3950.00
(Single User License)
Global Cefoperazone Sodium Market Insights, Forecast to 2030
It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.
Published Date: 2024-04-16
Pages: 110
USD 4900.00
(Single User License)
Cefoperazone Sodium - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.
Published Date: 2024-01-25
Pages: 124
USD 3950.00
(Single User License)
Global Cefoperazone Sodium Market Research Report 2024
It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.
Published Date: 2024-01-11
Pages: 96
USD 2900.00
(Single User License)

Cefoperazone Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cefoperazone Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 139
USD 3950.00 (Single User License)
Global Cefoperazone Sodium Market Research Report 2026
The global Cefoperazone Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 141
USD 2900.00 (Single User License)
Global Cefoperazone Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cefoperazone Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 158
USD 4900.00 (Single User License)
Global Cefoperazone Sodium Market Research Report 2025
The global market for Cefoperazone Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 104
USD 2900.00 (Single User License)
Cefoperazone Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cefoperazone Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 125
USD 3950.00 (Single User License)
Global Cefoperazone Sodium Market Insights, Forecast to 2030
It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.
Published: 2024-04-16
Pages: 110
USD 4900.00 (Single User License)
Cefoperazone Sodium - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.
Published: 2024-01-25
Pages: 124
USD 3950.00 (Single User License)
Global Cefoperazone Sodium Market Research Report 2024
It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.
Published: 2024-01-11
Pages: 96
USD 2900.00 (Single User License)